Financhill
Sell
37

AGEN Quote, Financials, Valuation and Earnings

Last price:
$4.08
Seasonality move :
-7.64%
Day range:
$4.13 - $4.26
52-week range:
$1.38 - $7.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.05x
P/B ratio:
--
Volume:
390.1K
Avg. volume:
464.4K
1-year change:
19.14%
Market cap:
$141.8M
Revenue:
$103.5M
EPS (TTM):
-$2.13

Analysts' Opinion

  • Consensus Rating
    Agenus, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $12.33, Agenus, Inc. has an estimated upside of 195.76% from its current price of $4.17.
  • Price Target Downside
    According to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $4.17.

Fair Value

  • According to the consensus of 3 analysts, Agenus, Inc. has 195.76% upside to fair value with a price target of $12.33 per share.

AGEN vs. S&P 500

  • Over the past 5 trading days, Agenus, Inc. has underperformed the S&P 500 by -4.8% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Agenus, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Agenus, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Agenus, Inc. reported revenues of $30.2M.

Earnings Growth

  • Agenus, Inc. has grown year-over-year earnings for 9 quarters straight. In the most recent quarter Agenus, Inc. reported earnings per share of $1.94.
Enterprise value:
472.6M
EV / Invested capital:
7.87x
Price / LTM sales:
1.05x
EV / EBIT:
--
EV / Revenue:
4.42x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-5.29x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$93M
Return On Assets:
-18.12%
Net Income Margin (TTM):
-36.77%
Return On Equity:
--
Return On Invested Capital:
-39.69%
Operating Margin:
-16.08%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $100.9M $160.4M $106.8M $25.1M $30.2M
Gross Profit $80.1M $144.5M $93M $21.6M $26.6M
Operating Income -$213.4M -$100.8M -$62.9M -$33.4M -$4.9M
EBITDA -$203.1M -$85.5M -$50.3M -$30M -$1.8M
Diluted EPS -$16.33 -$11.00 -$2.13 -$3.08 $1.94
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $308.4M $251.4M $125.6M $50.2M $134M
Total Assets $437.6M $429M $335.5M $238.5M $233.9M
Current Liabilities $150.1M $173.1M $198.4M $270.6M $287.1M
Total Liabilities $402.1M $440.9M $450.8M $510.3M $514.8M
Total Equity $35.6M -$11.8M -$115.3M -$271.8M -$280.9M
Total Debt $307.5M $348.5M $352M $418.2M $339.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$231.1M -$170.1M -$89.2M -$53.3M -$14.7M
Cash From Investing -$5.8M $2.9M $393K $56K $76K
Cash From Financing $136.3M $105.8M $45.6M $4.6M $6.7M
Free Cash Flow -$260.6M -$165.4M -$89.3M -$53.3M -$14.7M
AGEN
Sector
Market Cap
$141.8M
$28.4M
Price % of 52-Week High
56.81%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-16.31%
-1.32%
1-Year Price Total Return
19.14%
-22.19%
Beta (5-Year)
1.510
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $4.33
200-day SMA
Buy
Level $3.94
Bollinger Bands (100)
Sell
Level 3.86 - 5.24
Chaikin Money Flow
Sell
Level -623.1M
20-day SMA
Sell
Level $4.24
Relative Strength Index (RSI14)
Sell
Level 47.66
ADX Line
Buy
Level 23.5
Williams %R
Neutral
Level -79.661
50-day SMA
Buy
Level $4.12
MACD (12, 26)
Buy
Level 0.05
25-day Aroon Oscillator
Buy
Level 12
On Balance Volume
Neutral
Level 263.1M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-15.7231)
Sell
CA Score (Annual)
Level (-8.8244)
Buy
Beneish M-Score (Annual)
Level (-5.3046)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (16.7741)
Sell
Piotroski F Score (Annual)
Level (2)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Stock Forecast FAQ

In the current month, AGEN has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AGEN average analyst price target in the past 3 months is $12.33.

  • Where Will Agenus, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Agenus, Inc. share price will rise to $12.33 per share over the next 12 months.

  • What Do Analysts Say About Agenus, Inc.?

    Analysts are divided on their view about Agenus, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Agenus, Inc. is a Sell and believe this share price will drop from its current level to $6.00.

  • What Is Agenus, Inc.'s Price Target?

    The price target for Agenus, Inc. over the next 1-year time period is forecast to be $12.33 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is AGEN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Agenus, Inc. is a Buy. 2 of 3 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of AGEN?

    You can purchase shares of Agenus, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Agenus, Inc. shares.

  • What Is The Agenus, Inc. Share Price Today?

    Agenus, Inc. was last trading at $4.08 per share. This represents the most recent stock quote for Agenus, Inc.. Yesterday, Agenus, Inc. closed at $4.17 per share.

  • How To Buy Agenus, Inc. Stock Online?

    In order to purchase Agenus, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock